[1] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medicalassociation; Chinese Society of Infectious Diseases,Chinese Medical Association. Chinese consensus on the diagnosis and management of autoimmune hepatitis(2015)[J]. J Clin Hepatol,2016,32(1):9-22.(in Chinese)中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识(2015)[J].临床肝胆病杂志,2016,32(1):9-22.
|
[2] ANAYA JM,RAMIREZ-SANTANA C,ALZATE MA,et al. The auto immune ecology[J]. Front Immunol,2016,7:139.
|
[3] DOHERTY DG. Immunity,tolerance and autoimmunity in the liver:A comprehensive review[J]. J Autoimmun,2016,66:60-75.
|
[4] CHOI J,SELMI C,LEUNG PS,et al. Chemokine and chemokine receptors in autoimmunity:The case of primary biliary cholangitis[J]. Expet Rev Clin Immunol,2016,12(6):661-672.
|
[5] RIAZ A,ILAN N,VLODAVSKY I,et al. Characterization of heparinase induced phosphatidylinositol 3-kinase-AKT activation and its integrin dependence[J]. J Biol Chem,2013,288(17):12366-12375.
|
[6] ADEOYE GO,ALIMBA CG,OYELEKE OB. The genotoxicity and systemic toxicity of a pharmaceutical effluent in Wistar rats may involve oxidative stress induction[J]. Toxicology Reports,2015,2:1265-1272.
|
[7] ARNDTZ K,HIRSCHFIELD GM. The pathogenesis of autoimmune liver disease[J]. Dig Dis,2016,34(4):327–333.
|
[8] CUSICK MF,LIBBEY JE,FUJINAMI RS. Molecular mimicry as a mechanism of autoimmune disease[J]. Clin Rev Allergy Immunol,2012,42(1):102-111.
|
[9] ANAYA JM,RESTREPO-JIMNEZ P,RAMREZ-SANTANA C. The autoimmune ecology:An update[J]. Curr Opin Rheumatol,2018,30(4):350-360.
|
[10] CHEN J,ZHANG J,HE QS. Role of Toll-like receptors in development and progression of nonalcoholic fatty liver disease[J]. J Clin Hepatol,2015,31(7):1153-1155.(in Chinese)陈杰,张晶,何秋水. Toll样受体在非酒精性脂肪性肝病发生发展中的作用[J].临床肝胆病杂志,2015,31(7):1153-1155.
|
[11] CZAJA AJ. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis[J]. World J Gastroenterol,2016,22(42):9257-9278.
|
[12] HUANG CY,CHEN J,LIU YM,et al. Role of intestinal flora in the development/progression and treatment of autoimmune liver diseases[J]. J Clin Hepatol,2019,35(1):52-54.(in Chinese)黄春洋,陈杰,刘燕敏,等.肠道菌群在自身免疫性肝病发生发展及治疗中的作用[J].临床肝胆病杂志,2019,35(1):52-54.
|
[13] LIN R,ZHOU L,ZHANG J,et al. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis[J].Int. J Clin Exp Pathol,2015,8(5):5153-5160.
|
[14] VENTO S,GAROFANO T,DI PERRI G,et al. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitistype 1 in susceptible individuals[J]. Lancet,1991,337(8751):1183-1187.
|
[15] FLOREANI A,RESTREPO-JIMNEZ P,SECCHI MF,et al.Etiopathogenesis of autoimmune hepatitis[J]. J Autoimmun,2018,95(12):133-143.
|
[16] VERGANI D,MIELI-VERGANI G. Autoimmune manifestations in viral hepatitis[J]. Semin Immunopathol,2013,35(1):73-85.
|
[17] BADIANI RG,BECKER V,PEREZ RM,et al. Is autoimmune hepatitis a frequent finding among HCV patients with intense interface hepatitis?[J]. World J Gastroenterol,2010,16(29):3704-3708.
|
[18] TAUBERT R,DIESTELHORST J,JUNGE N,et al. Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis[J]. Sci Rep,2018,8(1):17452.
|
[19] PAIARDINI A,PASCARELLA S. Structural mimicry between SLA/LP and Rickettsia surface antigens as a driver of autoimmune hepatitis:Insights from an in silico study[J]. Theor Biol Med Model,2013,10(3):25.
|
[20] TUNCCAN OG,TUFAN A,TELLI G,et al. Visceral leishmaniasis mimicking autoimmune hepatitis,primary biliary cirrhosis,and systemic lupus erythematosus overlap[J]. Korean J Parasitol,2012,50(2):133-136.
|
[21] THIELE GM,DURYEE MJ,WILLIS MS,et al,Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites[J]. Alcohol Clin Exp Res,2010,34(12):2126-2136.
|
[22] COLOTTA F,JANSSON B,BONELLI F. Modulation of inflammatory and immune responses by vitamin D[J]. J Autoimmun,2017,85(12):78-97.
|
[23] LUONG KV,NGUYEN LT. The role of vitamin D in autoimmune hepatitis[J]. J Clin Med Res,2013,5(6):407-415.
|
[24] EFE C,KAV T,AYDIN C,et al. Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis[J].Dig Dis Sci,2014,59(12):3035-3042.
|
[25] HE Y,ZHAN J. Advances in drug-induced autoimmune hepatitis[J]. J Prac Hepatol,2013,16(2):178-180.(in Chinese)何艳,詹俊.药物诱导的自身免疫性肝炎研究进展[J].实用肝脏病杂志,2013,16(2):178-180.
|
[26] DELEMOS AS,FOUREAU DM,JACOBS C,et al. Drug-induced liver injury with autoimmune features[J]. Semin Liver Dis,2014,34(2):194-204.
|